ANDREWS RONALD ASBURY
Insider CIK 1299153 · PRPO Director · LIFE President, Medical Sciences · CNSY Director · OXFD Director · OCX President & CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNSY CERENOME, INC. | M Exercise deriv | 2026-10-01 | 2026-10-01 | 921 | — | $0 | 1,843 | SEC↗ |
| CNSY CERENOME, INC. | M Exercise | 2026-10-01 | 2026-10-01 | 921 | — | $0 | 1,843 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | M Exercise deriv | 2026-07-01 | 2026-07-01 | 922 | — | $0 | 2,764 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | M Exercise | 2026-07-01 | 2026-07-01 | 922 | — | $0 | 922 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | A Award deriv | 2026-05-14 | 2026-05-18 | 3,686 | — | $0 | 3,686 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | A Award deriv | 2026-05-14 | 2026-05-18 | 1,600 | — | $0 | 1,600 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | A Award deriv | 2026-05-14 | 2026-05-18 | 3,686 | — | $0 | 3,686 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 1,500 | — | $0 | 1,500 | SEC↗ |
| PRPO Precipio, Inc. | A Award | 2025-10-15 | 2026-01-20 | 568 | $17.58 | $10.0K | 15,796 | SEC↗ |
| PRPO Precipio, Inc. | A Award | 2025-10-15 | 2025-10-16 | 568 | $17.58 | $10.0K | 15,708 | SEC↗ |
| PRPO Precipio, Inc. | A Award | 2025-07-16 | 2025-07-18 | 676 | $14.78 | $10.0K | 15,228 | SEC↗ |
| PRPO Precipio, Inc. | A Award | 2025-04-15 | 2025-04-17 | 1,785 | $5.60 | $10.0K | 14,552 | SEC↗ |
| PRPO Precipio, Inc. | A Award | 2025-01-15 | 2025-01-16 | 1,639 | $6.10 | $10.0K | 12,767 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2025-01-14 | 2025-01-16 | 1,000 | — | $0 | 1,000 | SEC↗ |
| PRPO Precipio, Inc. | A Award | 2024-10-15 | 2024-10-17 | 1,510 | $6.62 | $10.0K | 11,128 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2024-08-31 | 2024-09-06 | 258 | — | $0 | 258 | SEC↗ |
| PRPO Precipio, Inc. | D To issuer deriv | 2024-08-31 | 2024-09-06 | 2,000 | — | $0 | 0 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2024-08-31 | 2024-09-06 | 1,250 | — | $0 | 1,250 | SEC↗ |
| PRPO Precipio, Inc. | D To issuer deriv | 2024-08-31 | 2024-09-06 | 1,250 | — | $0 | 0 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2024-08-31 | 2024-09-06 | 2,000 | — | $0 | 2,000 | SEC↗ |
| PRPO Precipio, Inc. | D To issuer deriv | 2024-08-31 | 2024-09-06 | 258 | — | $0 | 0 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2024-08-31 | 2024-09-06 | 103 | — | $0 | 103 | SEC↗ |
| PRPO Precipio, Inc. | D To issuer deriv | 2024-08-31 | 2024-09-06 | 103 | — | $0 | 0 | SEC↗ |
| PRPO Precipio, Inc. | A Award | 2024-07-15 | 2024-07-16 | 2,157 | $4.63 | $10.0K | 9,618 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2024-06-21 | 2024-06-25 | 1,000 | — | $0 | 1,000 | SEC↗ |
| PRPO Precipio, Inc. | A Award | 2024-04-15 | 2024-04-17 | 3,153 | $6.66 | $21.0K | 7,461 | SEC↗ |
| PRPO Precipio, Inc. | A Award | 2023-10-24 | 2023-10-26 | 4,005 | — | $0 | 4,308 | SEC↗ |
| PRPO Precipio, Inc. | A Award | 2023-09-12 | 2023-09-14 | 6,060 | — | $0 | 6,060 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2023-01-06 | 2023-01-10 | 30,000 | — | $0 | 30,000 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2022-12-07 | 2022-12-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OCX Oncocyte Corp | D To issuer deriv | 2022-12-01 | 2022-12-09 | 45,000 | — | $0 | 0 | SEC↗ |
| OCX Oncocyte Corp | D To issuer deriv | 2022-12-01 | 2022-12-09 | 250,000 | — | $0 | 250,000 | SEC↗ |
| OCX Oncocyte Corp | D To issuer deriv | 2022-12-01 | 2022-12-09 | 35,000 | — | $0 | 0 | SEC↗ |
| OCX Oncocyte Corp | D To issuer deriv | 2022-12-01 | 2022-12-09 | 93,750 | — | $0 | 281,250 | SEC↗ |
| OCX Oncocyte Corp | D To issuer deriv | 2022-12-01 | 2022-12-09 | 950,000 | — | $0 | 0 | SEC↗ |
| OCX Oncocyte Corp | D To issuer deriv | 2022-12-01 | 2022-12-09 | 50,000 | — | $0 | 0 | SEC↗ |
| OCX Oncocyte Corp | D To issuer deriv | 2022-12-01 | 2022-12-09 | 20,000 | — | $0 | 0 | SEC↗ |
| OCX Oncocyte Corp | D To issuer deriv | 2022-12-01 | 2022-12-09 | 500,000 | — | $0 | 0 | SEC↗ |
| OCX Oncocyte Corp | D To issuer deriv | 2022-12-01 | 2022-12-09 | 300,000 | — | $0 | 0 | SEC↗ |
| OCX Oncocyte Corp | M Exercise deriv | 2022-12-01 | 2022-12-09 | 250,000 | — | $0 | 0 | SEC↗ |
| OCX Oncocyte Corp | M Exercise | 2022-12-01 | 2022-12-09 | 250,000 | — | $0 | 583,212 | SEC↗ |
| OCX Oncocyte Corp | P Buy | 2022-08-16 | 2022-08-18 | 40,000 | $0.96 | $38.4K | 333,212 | SEC↗ |
| OCX Oncocyte Corp | P Buy | 2022-03-16 | 2022-03-17 | 50,000 | $1.28 | $64.0K | 293,212 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2022-03-15 | 2022-03-17 | 300,000 | — | $0 | 300,000 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2022-03-15 | 2022-03-17 | 500,000 | — | $0 | 500,000 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2022-03-15 | 2022-03-17 | 35,000 | — | $0 | 35,000 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2022-03-15 | 2022-03-17 | 375,000 | — | $0 | 375,000 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2022-03-15 | 2022-03-17 | 200,000 | — | $0 | 200,000 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2022-01-11 | 2022-01-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2021-08-03 | 2021-08-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| OCX OncoCyte Corp | M Exercise deriv | 2021-07-01 | 2021-07-02 | 65,000 | — | $0 | 0 | SEC↗ |
| OCX OncoCyte Corp | M Exercise | 2021-07-01 | 2021-07-02 | 65,000 | — | $0 | 259,046 | SEC↗ |
| OCX OncoCyte Corp | F Tax w/h | 2021-07-01 | 2021-07-02 | 15,834 | — | $0 | 243,212 | SEC↗ |
| OCX OncoCyte Corp | F Tax w/h | 2021-06-30 | 2021-07-02 | 25,873 | — | $0 | 194,046 | SEC↗ |
| OCX OncoCyte Corp | M Exercise deriv | 2021-05-07 | 2021-07-02 | 106,221 | — | $0 | 0 | SEC↗ |
| OCX OncoCyte Corp | M Exercise | 2021-05-07 | 2021-07-02 | 106,221 | — | $0 | 219,919 | SEC↗ |
| OCX OncoCyte Corp | P Buy | 2021-03-19 | 2021-03-22 | 11,000 | $4.79 | $52.7K | 113,698 | SEC↗ |
| OXFD Oxford Immunotec Global PL | D To issuer deriv | 2021-03-08 | 2021-03-12 | 9,494 | $9.04 | $85.8K | 0 | SEC↗ |
| OXFD Oxford Immunotec Global PL | D To issuer deriv | 2021-03-08 | 2021-03-12 | 7,457 | $9.50 | $70.8K | 0 | SEC↗ |
| OXFD Oxford Immunotec Global PL | D To issuer deriv | 2021-03-08 | 2021-03-12 | 14,914 | $9.50 | $141.7K | 0 | SEC↗ |
| OXFD Oxford Immunotec Global PL | D To issuer deriv | 2021-03-08 | 2021-03-12 | 7,457 | $7.56 | $56.4K | 0 | SEC↗ |
| OXFD Oxford Immunotec Global PL | D To issuer deriv | 2021-03-08 | 2021-03-12 | 7,457 | $7.51 | $56.0K | 0 | SEC↗ |
| OXFD Oxford Immunotec Global PL | D To issuer deriv | 2021-03-08 | 2021-03-12 | 7,457 | $7.54 | $56.2K | 0 | SEC↗ |
| OXFD Oxford Immunotec Global PL | D To issuer deriv | 2021-03-08 | 2021-03-12 | 7,457 | $13.35 | $99.6K | 0 | SEC↗ |
| OXFD Oxford Immunotec Global PL | D To issuer | 2021-03-08 | 2021-03-12 | 4,081 | $22.00 | $89.8K | 0 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2021-03-01 | 2021-03-04 | 5,171 | — | $0 | 5 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2021-03-01 | 2021-03-04 | 2,069 | — | $0 | 2,069 | SEC↗ |
| OCX OncoCyte Corp | A Award deriv | 2021-02-25 | 2021-03-01 | 500,000 | $5.34 | $2.67M | 500,000 | SEC↗ |
| OCX OncoCyte Corp | P Buy | 2020-08-03 | 2020-08-04 | 40,000 | $1.35 | $54.0K | 102,698 | SEC↗ |
| OXFD Oxford Immunotec Global PL | A Award deriv | 2020-06-24 | 2020-06-26 | 9,494 | — | $0 | 9,494 | SEC↗ |
| OXFD Oxford Immunotec Global PL | A Award | 2020-06-24 | 2020-06-26 | 4,081 | — | $0 | 4,081 | SEC↗ |
| OCX OncoCyte Corp | A Award deriv | 2020-05-07 | 2020-05-12 | 106,221 | — | $0 | 106,221 | SEC↗ |
| OCX OncoCyte Corp | P Buy | 2020-03-31 | 2020-04-01 | 18,000 | $2372.00 | $42.70M | 62,698 | SEC↗ |
| OCX OncoCyte Corp | P Buy | 2020-03-31 | 2020-04-01 | 18,000 | $2.37 | $42.7K | 62,698 | SEC↗ |
| OCX OncoCyte Corp | P Buy | 2020-03-30 | 2020-04-01 | 27,216 | $2.26 | $61.5K | 44,698 | SEC↗ |
| OCX OncoCyte Corp | P Buy | 2020-03-30 | 2020-04-01 | 27,216 | $2.26 | $61.5K | 44,698 | SEC↗ |
| OCX OncoCyte Corp | A Award deriv | 2019-07-01 | 2019-07-03 | 950,000 | — | $0 | 950,000 | SEC↗ |
| OXFD Oxford Immunotec Global PL | A Award deriv | 2019-06-18 | 2019-06-19 | 7,457 | — | $0 | 7,457 | SEC↗ |
| OCX OncoCyte Corp | A Award deriv | 2018-08-30 | 2018-09-04 | 45,000 | — | $0 | 45,000 | SEC↗ |
| OCX OncoCyte Corp | P Buy deriv | 2018-07-26 | 2018-07-31 | 17,482 | — | $0 | 17,482 | SEC↗ |
| OCX OncoCyte Corp | P Buy | 2018-07-26 | 2018-07-31 | 17,482 | — | $0 | 17,482 | SEC↗ |
| OXFD Oxford Immunotec Global PL | A Award deriv | 2018-06-19 | 2018-06-21 | 7,457 | — | $0 | 7,457 | SEC↗ |
| OXFD Oxford Immunotec Global PL | A Award deriv | 2017-06-06 | 2017-06-08 | 7,457 | — | $0 | 7,457 | SEC↗ |
| OXFD Oxford Immunotec Global PL | A Award deriv | 2016-06-28 | 2016-06-29 | 7,457 | — | $0 | 7,457 | SEC↗ |
| OXFD Oxford Immunotec Global PL | A Award deriv | 2015-11-04 | 2015-11-06 | 14,914 | — | $0 | 14,914 | SEC↗ |
| OXFD Oxford Immunotec Global PL | A Award deriv | 2015-11-04 | 2015-11-06 | 7,457 | — | $0 | 7,457 | SEC↗ |
| LIFE Life Technologies Corp | D To issuer deriv | 2014-02-03 | 2014-02-04 | 44,671 | $48.99 | $2.19M | 0 | SEC↗ |
| LIFE Life Technologies Corp | D To issuer deriv | 2014-02-03 | 2014-02-04 | 12,776 | — | $0 | 0 | SEC↗ |
| LIFE Life Technologies Corp | D To issuer deriv | 2014-02-03 | 2014-02-04 | 21,337 | $48.91 | $1.04M | 0 | SEC↗ |
| LIFE Life Technologies Corp | D To issuer deriv | 2014-02-03 | 2014-02-04 | 4,259 | — | $0 | 12,776 | SEC↗ |
| LIFE Life Technologies Corp | D To issuer deriv | 2014-02-03 | 2014-02-04 | 3,067 | — | $0 | 6,133 | SEC↗ |
| LIFE Life Technologies Corp | D To issuer deriv | 2014-02-03 | 2014-02-04 | 6,133 | — | $0 | 0 | SEC↗ |
| LIFE Life Technologies Corp | D To issuer deriv | 2014-02-03 | 2014-02-04 | 7,144 | — | $0 | 3,572 | SEC↗ |
| LIFE Life Technologies Corp | D To issuer deriv | 2014-02-03 | 2014-02-04 | 3,572 | — | $0 | 0 | SEC↗ |
| LIFE Life Technologies Corp | D To issuer | 2014-02-03 | 2014-02-04 | 7,357 | $76.13 | $560.1K | 0 | SEC↗ |
| LIFE Life Technologies Corp | D To issuer deriv | 2014-01-17 | 2014-01-22 | 13,546 | — | $0 | 0 | SEC↗ |
| LIFE Life Technologies Corp | M Exercise deriv | 2013-04-02 | 2013-04-03 | 3,067 | — | $0 | 9,200 | SEC↗ |
| LIFE Life Technologies Corp | F Tax w/h | 2013-04-02 | 2013-04-03 | 1,213 | $65.75 | $79.8K | 7,357 | SEC↗ |
| LIFE Life Technologies Corp | M Exercise | 2013-04-02 | 2013-04-03 | 3,067 | $65.75 | $201.7K | 8,570 | SEC↗ |
| LIFE Life Technologies Corp | A Award deriv | 2013-04-01 | 2013-04-02 | 17,035 | — | $0 | 17,035 | SEC↗ |
| LIFE Life Technologies Corp | A Award deriv | 2013-03-29 | 2013-04-02 | 8,509 | — | $0 | 8,509 | SEC↗ |
| LIFE Life Technologies Corp | M Exercise deriv | 2013-02-01 | 2013-02-05 | 3,572 | — | $0 | 0 | SEC↗ |
| LIFE Life Technologies Corp | F Tax w/h | 2013-02-01 | 2013-02-05 | 1,399 | $65.24 | $91.3K | 5,503 | SEC↗ |
| LIFE Life Technologies Corp | M Exercise | 2013-02-01 | 2013-02-05 | 3,572 | $65.24 | $233.0K | 6,902 | SEC↗ |
| LIFE Life Technologies Corp | P Buy | 2012-04-27 | 2012-05-01 | 3,330 | $46.49 | $154.8K | 3,330 | SEC↗ |
| LIFE Life Technologies Corp | A Award deriv | 2012-04-02 | 2012-04-04 | 12,267 | — | $0 | 12,267 | SEC↗ |
| LIFE Life Technologies Corp | A Award deriv | 2012-04-02 | 2012-04-04 | 21,337 | — | $0 | 21,337 | SEC↗ |